ORANGEBURG, N.Y., Jan. 13, 2014 (GLOBE NEWSWIRE) -- An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hospital, located just outside of Chicago.*
"This type of outbreak not only undermines patient confidence, it creates stiff potential financial liabilities for hospitals and other healthcare facilities under the Affordable Care Act," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences, Inc. (Nasdaq:VSCI) – a company specializing in endoscopes that help safeguard patients from cross-contamination infections caused by conventional endoscopes.
Vision-Sciences ( www.visionsciences.com ) provides patented technology solutions that safeguard patients with a sterile cover, or EndoSheath® Technology , for its endoscopes. This prevents direct contact of the scope with the patient and reduces the risk of contracting infections from bacteria such as the Nightmare Bacteria as a result of endoscopic cross-contamination. In 20 years and with over 5 million procedures performed with EndoSheath® Technology, Vision-Sciences has never received a report of cross-contamination."We feel confident that our EndoSheath® Technology is a win-win for the healthcare facility and its patients. It is in our best interest to ensure that all healthcare professionals are aware of this alternative to conventional endoscopes while offering a cost cutting and liability reducing solution," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences. Mr. Pell and Mr. Zauberman are available for in-person meetings or phone interviews. Please contact Mitch Kayden at (845) 709-5607 for more information and to set up an interview. Important Summary Points -- The Affordable Care Act creates potential liability for all healthcare facilities for hospital-acquired infections. Vision Sciences® technology offers an option for hospitals to reduce liability and lower costs/overhead.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV